WDNA Holdings — WisdomTree BioRevolution Fund
All 86 reported holdings of WisdomTree BioRevolution Fund (WDNA) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Moderna Inc | 4.54% | $102.82K |
| Johnson & Johnson | 3.15% | $71.38K |
| United Therapeutics Corporation | 2.80% | $63.45K |
| Pfizer Inc. | 2.74% | $62.00K |
| Eli Lilly & Co. | 2.64% | $59.79K |
| Stoke Therapeutics Inc | 2.53% | $57.27K |
| Natera, Inc. | 2.53% | $57.20K |
| Amgen Inc. | 2.35% | $53.13K |
| Twist Bioscience Corporation | 2.32% | $52.41K |
| AstraZeneca PLC | 2.28% | $51.67K |
| Structure Therapeutics Inc | 2.20% | $49.84K |
| Amicus Therapeutics Inc. | 2.19% | $49.67K |
| BioNTech SE | 2.09% | $47.37K |
| Ionis Pharmaceuticals, Inc. | 2.06% | $46.63K |
| Gilead Sciences Inc. | 1.96% | $44.32K |
| CRISPR Therapeutics AG | 1.87% | $42.38K |
| Immunome Inc | 1.86% | $42.17K |
| Novonesis (Novozymes) B | 1.85% | $41.93K |
| Beam Therapeutics, Inc. | 1.82% | $41.13K |
| 10X Genomics Inc | 1.78% | $40.34K |
| Darling Ingredients, Inc | 1.70% | $38.47K |
| Novartis AG | 1.65% | $37.30K |
| Roivant Sciences Ltd | 1.60% | $36.20K |
| Krystal Biotech Inc | 1.57% | $35.65K |
| Agios Pharmaceuticals Inc | 1.57% | $35.45K |
| Bunge Global SA | 1.54% | $34.85K |
| Novo Nordisk A/S | 1.49% | $33.64K |
| Intellia Therapeutics Inc | 1.48% | $33.61K |
| Corteva Inc | 1.45% | $32.81K |
| Arrowhead Pharmaceuticals Inc | 1.43% | $32.42K |
| Vertex Pharmaceuticals Incorporated | 1.36% | $30.81K |
| Regenxbio Inc. | 1.32% | $29.93K |
| Arcellx Inc | 1.28% | $28.93K |
| Allogene Therapeutics Inc | 1.25% | $28.24K |
| Bristol-Myers Squibb Company | 1.20% | $27.11K |
| Takeda Pharmaceutical Co Ltd. | 1.17% | $26.42K |
| Regeneron Pharmaceuticals, Inc. | 1.13% | $25.50K |
| Genmab As | 1.10% | $24.98K |
| Verbio SE | 1.05% | $23.69K |
| Biomarin Pharmaceutical Inc. | 1.02% | $23.16K |
| Bayer AG | 1.01% | $22.96K |
| Argenx SE | 0.94% | $21.18K |
| Viking Therapeutics Inc. | 0.91% | $20.70K |
| Veracyte Inc | 0.91% | $20.52K |
| Editas Medicine Inc | 0.89% | $20.21K |
| Danaher Corporation | 0.89% | $20.10K |
| Arcturus Therapeutics Holdings Inc | 0.85% | $19.25K |
| Absci Corp. | 0.84% | $18.96K |
| Iovance Biotherapeutics Inc | 0.82% | $18.51K |
| Tempus AI Inc. | 0.78% | $17.64K |
| Merck & Co., Inc | 0.78% | $17.56K |
| Uniqure N.V. | 0.76% | $17.15K |
| Repligen Corporation | 0.75% | $17.08K |
| Biogen Inc | 0.74% | $16.68K |
| Exelixis, Inc. | 0.71% | $16.17K |
| Zoetis Inc. | 0.68% | $15.49K |
| Revolution Medicines Inc | 0.66% | $14.88K |
| Sana Biotechnology Inc | 0.64% | $14.41K |
| Halozyme Therapeutics Inc | 0.63% | $14.35K |
| Green Plains Inc. | 0.62% | $13.97K |
| Ginkgo Bioworks Holdings Inc | 0.59% | $13.43K |
| Zealand Pharma As | 0.57% | $12.92K |
| Bridgebio Pharma Inc | 0.56% | $12.77K |
| Syensqo SA | 0.54% | $12.31K |
| Geron Corp. | 0.53% | $11.93K |
| Ultragenyx Pharmaceuticals Inc | 0.52% | $11.73K |
| Genus PLC | 0.45% | $10.09K |
| Illumina Inc | 0.44% | $9.86K |
| Bio-Techne Corp | 0.43% | $9.67K |
| Sarepta Therapeutics Inc | 0.41% | $9.29K |
| Schrodinger Inc. | 0.38% | $8.50K |
| Tyson Foods, Inc. | 0.37% | $8.46K |
| Caribou Biosciences Inc | 0.37% | $8.38K |
| Alnylam Pharmaceuticals Inc. | 0.37% | $8.27K |
| Oxford Nanopore Technologies Plc | 0.36% | $8.12K |
| Recursion Pharmaceuticals Inc | 0.32% | $7.35K |
| Rocket Pharmaceuticals Inc | 0.32% | $7.28K |
| Drey Inst Pref Gov Mm-M | 0.32% | $7.18K |
| Nufarm Ltd. | 0.28% | $6.33K |
| Thermo Fisher Scientific Inc | 0.26% | $5.90K |
| Pacific Biosciences Of California Inc. | 0.25% | $5.77K |
| Qiagen NV | 0.24% | $5.41K |
| Fate Therapeutics Inc. | 0.22% | $5.03K |
| FMC Corp. | 0.20% | $4.60K |
| Biohaven Ltd | 0.15% | $3.29K |
| Dreyfus Trsy Oblig Cash M | 0.05% | $1.11K |
WDNA overview: performance, fees, allocation and SEC filings